KVK Tech Announces FDA-Approval of Lomaira (phentermine hydrochloride USP) for Weight Reduction

NEWTOWN, Pa., Sept. 20, 2016 /PRNewswire/ -- KVK Tech, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Lomaira (phentermine hydrochloride USP) 8 mg tablets CIV, a low-cost, low-dose prescription medicine used for a...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news